ALFA Filings
Every announcement, straight from the exchange
Every SMS Pharmaceuticals other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
2 announcements with these filters
SMS Pharmaceuticals Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026. This is a routine regulatory compliance filing.
SMS Pharmaceuticals disclosed two market sell trades by Designated Person NVV Satyanarayana totalling ₹0.14 Crore. The PIT Reg 7(2) intimation involves a non-promoter designated person.